Karuna Therapeutics, Inc.
(NASDAQ:KRTX)
$190.94
0.27 (0.14%)
At Close: 4:00 PM
KRTX Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
KRTX Stock Price Today
Karuna Therapeutics, Inc. (KRTX) stock rallied over 1.51% intraday to trade at $190.94 a share on NASDAQ. The stock opened with a loss of -11.62% at $168.52 and touched an intraday high of $168.52, rising 0.14% against the last close of $190.67. The Karuna Therapeutics, Inc. in stock market went to a low of $163.16 during the session.
KRTX Stock Snapshot
$190.67
Prev. Close
7.2 Billion
Market Cap
$163.16
Day Low
$168.52
Open
N/A
Number of Shares
$168.52
Day High
N/A
P/E ratio
-10.93
EPS (TTM)
35.56
Cash Flow per Share
N/A
Free Float in %
35.06
Book Value
298749.00
Volume
KRTX Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.08
Sales or Revenue$5.93 Million
5Y Sales Change-14.24%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Peers
Frequently Asked Questions
What is the current Karuna Therapeutics, Inc. (KRTX) stock price?
Karuna Therapeutics, Inc. (NASDAQ: KRTX) stock price is $190.94 in the last trading session. During the trading session, KRTX stock reached the peak price of $168.52 while $163.16 was the lowest point it dropped to. The percentage change in KRTX stock occurred in the recent session was 1.51% while the dollar amount for the price change in KRTX stock was $2.84.
KRTX's industry and sector of operation?
The NASDAQ listed KRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions.
Who are the executives of KRTX?
Dr. Andrew Craig Miller
Co-Founder & Chief Operating Officer
Dr. Steven M. Paul M.D.
Chief Executive Officer, Pres & Chairman
Dr. Ronald N. Marcus M.D.
Senior Vice President of Medical
Dr. Troy A. Ignelzi
Chief Financial Officer & Sec.
How KRTX did perform over past 52-week?
KRTX's closing price is 1.24% higher than its 52-week low of $158.375 where as its distance from 52-week high of $245 is -0.26%.
How many employees does KRTX have?
Number of KRTX employees currently stands at N/A. KRTX operates from 99 High Street, Boston, MA 02110, US.
Link for KRTX official website?
Official Website of KRTX is: https://www.karunatx.com
How do I contact KRTX?
KRTX could be contacted at phone #857 449 2244 and can also be accessed through its website. KRTX operates from 99 High Street, Boston, MA 02110, US.
How many shares of KRTX are traded daily?
KRTX stock volume for the day was 298749.00 shares. The average number of KRTX shares traded daily for last 3 months was 234.23 Thousands.
What is the market cap of KRTX currently?
The market value of KRTX currently stands at $7.2 Billion with its latest stock price at $190.94 and N/A of its shares outstanding.